On Wednesday, Umpqua Holdings Corp (NASDAQ:UMPQ)’s shares inclined 0.93% to $16.30.
Umpqua Holdings Corporation (UMPQ), parent company of Umpqua Bank and Umpqua Investments, declared that it will host its third quarter 2015 earnings conference call on Thursday, October 22, 2015, at 10:00 a.m. PST (1:00 p.m. EST). During the call, the Company will provide an update on recent activities and talk about its third quarter 2015 financial results, which are predictable to be released after the market closes on October 21, 2015. There will be a live question-and-answer session following the presentation.
Umpqua Holdings Corporation, through its auxiliaries, engages in the commercial and retail banking, and retail brokerage businesses. It operates through two segments, Community Banking and Home Lending.
EarthLink Holdings Corp. (NASDAQ:ELNK)’s shares gained 3.73% to $7.78.
EarthLink Holdings Corp. (ELNK), a leading managed network, security and cloud solutions provider, and IRONMAN, the largest participation sports platform in the world, are proud to declare a multi-year partnership during which EarthLink will serve as the Official Technology Partner of the IRONMAN® U.S. Series. From WiFi to safeguarding payments and tracking athlete progress, IRONMAN will leverage EarthLink’s technology services and expertise to enhance the event experience for its entire community of athletes, families and spectators.
As part of the partnership, EarthLink will review race experiences and work with IRONMAN to implement technology and network changes that will improve athlete tracking, event communications, and data security. The aim is to ensure that the entire IRONMAN community will benefit from these enhancements, counting athletes, spectators, remotely located friends and family members, and on-site IRONMAN Village exhibitors.
EarthLink Holdings Corp., together with its subsidiaries, provides managed network, security, and cloud services to business and residential customers in the United States. The company operates in two segments, Business Services and Consumer Services.
At the end of Wednesday’s trade, Mack Cali Realty Corp (NYSE:CLI)‘s shares dipped -0.94% to $18.88.
Mack-Cali Realty Corporation (CLI) and Ironstate Development Company declared recently the topping out of URL® Harborside 1 at 713 feet, making the new multi-family tower on the Jersey City waterfront the tallest residential building in New Jersey.
Jersey City Mayor Steven Fulop and fellow municipal officials joined the development partners and more than 200 tradespeople to celebrate the construction milestone of URL® Harborside 1, a uniquely-designed, 69-story residential tower that will bring 763 contemporary rental residences to Mack-Cali’s Harborside in downtown Jersey City. The about $330 million development, the first phase of what will ultimately feature three towers comprising 2,358 residences overlooking the Manhattan skyline, is predictable to open for leasing in the fourth quarter of 2016. The ambitious project has created hundreds of jobs in Jersey City, counting construction and eventual full-time employment opportunities.
Mack-Cali Realty Corporation is a real estate investment trust (REIT). It engages in the leasing, administration, acquisition, development, and construction of commercial real estate properties in the United States.
Sangamo Biosciences, Inc. (NASDAQ:SGMO), ended its Wednesday’s trading session shares showed no change, and closed at $5.64.
Sangamo BioSciences, Inc. (SGMO), a leader in therapeutic genome editing, declared that Elizabeth Wolffe, Ph.D., Sangamo’s vice president of corporate communications, will provide an update on the progress of Sangamo’s ZFP Therapeutic® development programs and an overview of the company’s business strategy at 2:30pm PT on Wednesday, October 7, 2015, at the 2015 Stem Cell Meeting on the Mesa. In addition, as the Chairman of the Alliance for Regenerative Medicine (ARM), Edward Lanphier, Sangamo’s president and chief executive officer, will open the meeting with a welcome address. The meeting will be held from October 7-9 in La Jolla, California.
Sangamo BioSciences, Inc., a clinical stage biopharmaceutical company, focused on the research, development, and commercialization of engineered DNA-binding proteins as novel therapeutic products for various monogenic and infectious diseases with unmet medical needs. Its proprietary zinc finger DNA-binding protein (ZFP) technology enables precise and highly specific genome modification and gene regulation.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
